# TDOC — Teladoc Health · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** TDOC  
**Sources:** 18  
**Published:** 2026-10-23  
**Canonical:** https://app.k3vl4r.com/research/deep-research-tdoc-teladoc-health-catalysts-narrative-risks-8724

---

## Overview

Teladoc Health, Inc. (NYSE: TDOC) is a NYSE-listed healthcare company in the "Health Information Services" sector that provides virtual-care services worldwide, including general medical, mental-health (BetterHelp), and chronic-care (former Livongo) offerings [previous knowledge; 3]. As of late October 2026 the stock trades near multi-year lows on a market capitalization of roughly $1.1B–$1.15B, with a 52-week range of $4.40–$9.89 [3; 4; 17]. Note that share-price snapshots conflict across sources: the most recent prints sit near $6.30–$6.33 [7; 17], versus $5.82 on October 16 [[3]](https://walnutinvest.com/stocks/tdoc/is-it-a-buy-or-sell) and $5.56 on October 7 [[4]](https://www.ad-hoc-news.de/boerse/news/nebenwerte/teladoc-health-stock-launches-new-ai-tools-for-hospitals/70260321), indicating a rebound in mid-October and a ~40% decline over the three months following the Q2 report [[3]](https://walnutinvest.com/stocks/tdoc/is-it-a-buy-or-sell).

## Key recent catalysts (last ~1–3 months)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-tdoc-teladoc-health-catalysts-narrative-risks-8724 (free to sign up)._
